Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Adcetris
Pharma
Pfizer's blockbuster ADC Adcetris nabs FDA nod in LBCL
While CAR-T therapies also boast approvals in third-line large B-cell lymphoma, Pfizer apparently is not trying to compete with those products.
Angus Liu
Feb 12, 2025 3:06pm
ASH: Adcetris, Opdivo boost hopes for another ADC, PD-1 combo
Dec 10, 2023 7:30pm
Seagen CEO on his next stop, the Pfizer deal and ADCs
Jun 8, 2023 11:36am
ASCO: Seagen's top-selling drug under threat from Opdivo
Jun 4, 2023 8:00am
Pfizer snaps up ADC cancer specialist Seagen for $43B
Mar 13, 2023 10:51am
Seagen's revenue up 25% in 2022 as growth drivers 'firing'
Feb 16, 2023 10:42am
